Product Information File: Why the Toxicologist Plays a Central Role in Cosmetic Safety

Product Information File structure for cosmetic products showing key components including safety assessment, formulation data and regulatory documentation.

The Product Information File, commonly referred to as the PIF, is one of the cornerstone documents required to demonstrate the safety and regulatory compliance of cosmetic products in the European Union. Under the provisions of the Regulation (EC) No 1223/2009, every cosmetic product placed on the market must be supported by a complete and up […]

Safety Data Sheets: Regulatory Requirements, Compliance and Chemical Risk Management

Safety Data Sheets, commonly referred to as SDSs, are essential regulatory documents for communicating information on chemical hazards, safe handling, exposure controls and emergency measures. An accurate and up to date SDS supports regulatory compliance, occupational safety and effective chemical risk management throughout the supply chain. The regulatory requirements governing Safety Data Sheets vary across […]

Non-Genotoxic Impurities Qualification: A Risk Based and Scientifically Justified Approach

The control and qualification of impurities remain among the most critical aspects in the development and lifecycle management of pharmaceutical products. However, the recently published reflection paper from the European Medicines Agency signals an important evolution in how non-genotoxic impurities should be assessed, justified, and managed during pharmaceutical development. Until recently, qualification of non-genotoxic impurities […]

Navigating ICH Q3E: A Critical Look at Risk Assessment for Extractables and Leachables

Navigating ICH Q3E: A Critical Look at Risk Assessment for Extractables and Leachables

The newly released draft of the ICH Q3E guideline represents a significant milestone in the harmonisation of global expectations for the assessment and control of extractables and leachables (E&L) in pharmaceutical products. Building on the foundations laid by ICH Q3A, Q3B, Q3C, Q3D, and M7, it distinguishes itself by adopting a more integrated and systematic […]

Glyphosate under scrutiny again: what the new carcinogenicity data means for EU safety levels

Glyphosate

Glyphosate has been undes scrutiny since many years. Discovered in 1970 by a scientist at Monsanto, and since commercialization in 1974, its use has grown to dominate the herbicide market. Over the years, several epidemilogical studies were published, linking the chemical to adverse human health outcomes. Nine epidemiological studies were centered on neurodegenerative outcomes (two […]

Environmental Risk Assessment of Medicinal Products: A Streamlined Regulatory Overview

Tox Hub Blog – Expert Insights on Toxicology & Regulatory Topics

The Environmental Risk Assessment (ERA) play a key role in regulatory submissions for medicines in the European Union. The European Medicines Agency (EMA) requires a clear, evidence-based process to assess the potential environmental impact of active pharmaceutical ingredients (APIs) that enter the environment through patient use. With the updated EMA guideline (EMEA/CHMP/SWP/4447/00 Rev. 1 – EMA […]